Are you six months away from your bivalent Covid-19 booster and wondering when you’ll be able to get any other vaccines?
If you live in the UK or Canada, you already have your answer. The governments of Canada and the United Kingdom, following the recommendations of expert committees, plan to offer spring booster shots to those who are most at risk of contracting severe Covid illness.
But in the U. S. , there has been a radio silence from the Food and Drug Administration about the spring retreats factor, creating frustration among a small, determined organization of others who wish they didn’t have to wait until the fall to get some other dose of the Covid vaccine.
advertising
“I will tell you that patients message me every day about this,” Camille Kotton, clinical director of transplantation and immunocompromised host infectious diseases at Massachusetts General Hospital, told STAT.
Jamie Loehr, a family physician in Ithaca, N. Y. , has patients who won the updated reminder last fall and are now asking him to give them proof of clearance of default for a momentary bivalent injection.
advertising
“There are other people who actively need regular updates on this,” Loehr said in a discussion about the long-term covid vaccination at the meeting of the Advisory Committee on Immunization Practices, a specialized organization that advises the Centers for Disease Control and Prevention, which was held last February. Prevention in vaccination policy. Loehr and Kotton are members of CPIA.
Despite the FDA’s lack of direction, there is evidence that the company thought about the factor even last fall. One booster a year would not be enough for the elderly and immunocompromised people.
“I’d be lying to you if [I told you] that it doesn’t leave me up at night worried that there’s any possibility that we’re going to have to implement some other withdrawal, at least for some of the population, maybe older other people, before September, next October,” Marks said at the time.
The FDA declined an interview request from Marks for this article. In an email, the company sidestepped most STAT questions, saying only about the spring boosters factor that “We continue to closely monitor emerging knowledge in the U. S. “We will base any decisions on further up-to-date drivers on this knowledge. “
Evidence to date suggests that Covid vaccines offer robust coverage against serious illness, hospitalization, and death. But their ability to avoid infection is short-lived.
With this in mind, the U. K. ‘s Joint Committee on Immunization and Immunization and Canada’s National Advisory Committee on Immunization have issued recommendations for high-risk Americans to have a chance to get vaccinated against covid this spring.
In the UK, where 82. 5% of others over 75 got a double retirement last autumn, the advice is for others over 75 or living in a nursing home or who are five and older and immunocompromised to be presented with a spring booster. provided that six months have passed since the last injection.
“To the maximum vulnerable population to severe Covid-19 disruptions, JCVI’s view is that offering a spring booster dose for those Americans is a proportionate reaction in 2023,” the organization said in a statement.
In making the recommendation, the head of vaccination at the UK Health Security Agency highlighted a recent accumulation of severe cases among the elderly. people hospitalized,” Ramsey said.
NACI, Canada’s vaccine advisory group, recently voted to propose that other people be allowed a spring booster if they are 80 or older, adult citizens of long-term care facilities, 18 years of age or older, and/or seriously immunocompromised, or are between 65 and 79 years old, especially if they have no known history of Covid infection in the past.
The UK’s advice is that known high-risk Americans “should” be given a reminder. The Canadian expert panel issued more flexible advice, saying the other high-risk people it knew “might” get an extra dose this spring, a technique that, in public fitness jargon, is called “permissive” advice.
The latter technique is one that other people would like to see followed in this country. Loehr, the family circle doctor, said at February’s ACIP assembly that he believes there are annual Covid boosters, but that other immunocompromised or elderly people over 65 have the option of getting a boost for now six months later, by consulting with a physical care facility provider.
Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, would go further, saying that other people 50 and older in the U. S. would be able to do so. UU. se will present them with the option of receiving a momentary boost. 2022, 97. 3% of other people who died from covid in this country were people over the age of 50.
“It’s a specific organization that you can target,” Osterholm said.
He affirmed what is evident to anyone after the adoption of the bivalent withdrawal in the US. In the US: doctors’ offices and pharmacies wouldn’t face a tsunami of other people looking for a spring retreat, if one were allowed. Only 16. 3% of other people eligible for the updated vaccine won one; Even among the top-risk population, other people over the age of 65, less than a portion of those eligible, 41. 6%, have been vaccinated.
“Lately we live in a world where those who need extra booster doses need them. And those who don’t need them don’t need them at all. And what we’re looking to do is thread that needle,” Osterholm said.
“I think, given the knowledge we’ve observed about immunity declining over time, if someone wanted to get vaccinated every six months and was in a high-risk organization by age or underlying physical condition, then I think they would deserve to be allowed. I do not believe for a moment that this will be a widespread practice.
At the February meeting of the CPIA, members were informed that the Covid Vaccine Working Group, a subset of its members, had discussed whether to introduce spring boosters. But the organization concluded it didn’t have enough evidence to say another vaccine was needed at this time.
“The knowledge was not yet conclusive to identify the need for common vaccines and it was feared that it would not be imaginable to implement an immunization program in all adults over 65 twice a year,” Sara Oliver said. , an expert vaccine at the CDC, he said at the meeting.
Oliver also noted, however, that the Covid Task Force has stated that older adults and other immunocompromised people will likely remain more vulnerable to contracting serious illness if they contract Covid, and there is likely a need for more flexibility to deal with their conditions in the future.
“I actually like this concept of flexibility. And if the FDA makes the decision that there can be more flexibility around the recommendations, I think it will be helpful,” MGH’s Kotton said in the discussion.
But this flexibility does not exist lately. Bivalent Covid vaccines have not yet been authorized; are granted under the FDA’s Emergency Use Authorization. The regulations regarding the EUA are strict. Products covered by the U. S. The U. S. Food and Drug Administration will possibly only be used according to the FDA’s decision.
Once a vaccine is fully licensed, ACIP is free to propose a use that differs from FDA authorization. For example, the FDA appears to be on the verge of authorizing new respiratory syncytial virus vaccines for people 60 years of age and older. ACIP’s execution organization on RSV reported in February that cost-benefit analyses did not favor vaccine use in other people aged 60 to 64.
In the absence of FDA authorization for a spring recall, ACIP cannot do so.
While there are strong supporters of booster shots in the spring, everyone is convinced they are necessary.
“With a decline in hospitalizations and deaths, there is no movement toward a spring booster,” Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland School of Medicine, said in an email.
Neuzil noted that there are other equipment for other high-risk people who contract covid: antiviral drugs. “These are underutilized for the flu . . . And we don’t need them to be underutilized for COVID-19,” he said. They are a vital tool, especially for older adults and other immunocompromised people, and others are encouraged to contact their physical care providers early in their illness. “
In the interview with STAT, Kotton noted that things have improved especially for other immunocompromised people, their patient base, since the pandemic began. , is no longer used because the evolution of the virus that causes Covid has made it ineffective.
“I mean, overall, we’re seeing much lower rates of serious and life-threatening illness overall in other immunocompromised people and in the elderly compared to before,” he said. “For other people who are fully vaccinated, add a bivalent vaccine, and who have simple remedies like remdesivir, Paxlovid and other additional remedies, we’re now seeing much better overall results compared to what we were, say, a year ago or earlier. “
Kotton isn’t sure of the price of allowing a spring retreat.
“We don’t need to just give doses because other people are nervous, right?We need to make sure there is a smart, data-driven explanation for why we would need to administer more doses of the vaccine,” he said. Waiting, we’re waiting to hear more from the CDC and FDA. “
Coronavirus
public health
Report on the frontiers of medicine and
Unlimited to essential journalism in biotechnology, medicine and life sciences
Unlimited to the healthcare news and data you need
Unlimited to essential journalism in biotechnology, medicine and life sciences